Related news for: cancer immunotherapy
Dr Joshua Tobin a haematologist-in-training at Mater has been awarded the prestigious 2019 Celgene Future Leaders in Hematology Award in Orlando, Florida on Saturday 7 December.
Dr Josh Tobin receives 2019 Celgene Award
Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular lymphoma (FL).
Mater researcher investigates a new therapeutic approach for follicular lymphoma
Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.
$3.6 million awarded to develop treatment for relapsed lymphoma patients
Dr Cameron Turtle, a leading hematology oncologist and bone marrow transplant specialist at the Fred Hutchinson Cancer Research Center returned to Mater Research to share his latest research.
From Brisbane to Washington: former Mater researcher returns to share advances in cancer research